MyFinsight
Home
Blog
About
Back
Balance Sheet
CNS Pharmaceuticals, Inc. (CNSP)
CNS Pharmaceuticals, Inc. (CNSP)
source: myfinsight.com
Cash and cash
equivalents
$19,985,000
(64.76%↑ Y/Y)
Prepaid expenses and
other current assets
$1,865,000
(-6.46%↓ Y/Y)
Deferred offering costs
$73,000
(415.06%↑ Y/Y)
Property and equipment,
net
$15,000
(294.32%↑ Y/Y)
Total current assets
$21,923,000
(55.07%↑ Y/Y)
Total noncurrent
assets
$15,000
(-95.95%↓ Y/Y)
Total assets
$21,938,000
(51.21%↑ Y/Y)
Total liabilities and
stockholders' equity
$21,938,000
(51.21%↑ Y/Y)
Total stockholders'
equity
$18,200,000
(38.67%↑ Y/Y)
Total liabilities
$3,738,000
(170.30%↑ Y/Y)
Accumulated deficit
-$107,800,000
(-18.33%↓ Y/Y)
Additional paid-in capital
$125,998,000
(20.89%↑ Y/Y)
Total current
liabilities
$3,738,000
(170.30%↑ Y/Y)
Common stock, 0.001 par
value, 300,000,000...
$2,000
(296.83%↑ Y/Y)
Accounts payable and
accrued expenses
$3,738,000
(196.40%↑ Y/Y)
Back